Boston Medical Group

Bremelanotide, also known as PT-141, is a groundbreaking medication used to treat several forms of sexual dysfunction, mainly low sexual desire in women, with an increasing awareness of its usefulness for treating erectile dysfunction (ED) in men as well. While it is FDA-approved under the name Vyleesi® for treating Hypoactive Sexual Desire Disorder (HSDD) in […]

For many veterans, the challenges of military service extend well beyond their active duty years. Erectile dysfunction (ED) is one of the most common and distressing conditions affecting veterans, yet it’s often underdiagnosed, undertreated, or managed with limited success through Department of Veterans Affairs (VA) programs. While VA healthcare providers may prescribe medications like sildenafil, […]

Premature ejaculation (PE) is a widespread yet often underdiscussed male sexual dysfunction, impacting millions of men across various age groups and backgrounds, with an estimated 30% of men experiencing it at least once in their lifetime. Defined by rapid ejaculation with minimal sexual stimulation—often before, during, or shortly after intercourse—PE can cause significant psychological distress, […]

Premature ejaculation (PE) is among the most common male sexual dysfunctions, affecting between 20% and 30% of sexually active men worldwide. Characterized by an inability to delay orgasm during intercourse, PE can disrupt relationships, lower self-confidence, and contribute to performance anxiety and even erectile dysfunction (ED). In the search for new and effective treatments, attention […]

Premature ejaculation (PE) is one of the most common yet misunderstood male sexual disorders, affecting men of all ages and often causing significant emotional distress and relationship difficulties. While nearly every man may occasionally ejaculate sooner than desired, true premature ejaculation involves consistently unwanted fast ejaculation, typically defined as under one minute of intravaginal ejaculatory […]